메뉴 건너뛰기




Volumn 41, Issue 6, 2014, Pages 1046-1056

Prognostic value of 18F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma

Author keywords

Neuroblastoma; Prognostic value

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; DOPA; FLUORINE 18; (3 IODOBENZYL)GUANIDINE; 6 FLUORODOPA F 18; RADIOPHARMACEUTICAL AGENT;

EID: 84900789874     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-014-2691-0     Document Type: Article
Times cited : (46)

References (25)
  • 1
    • 0033554684 scopus 로고    scopus 로고
    • Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group
    • 1:STN:280:DyaK1MvjsFGnsg%3D%3D 10519894 10.1056/NEJM199910143411601
    • Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999;341:1165-73.
    • (1999) N Engl J Med , vol.341 , pp. 1165-1173
    • Matthay, K.K.1    Villablanca, J.G.2    Seeger, R.C.3    Stram, D.O.4    Harris, R.E.5    Ramsay, N.K.6
  • 2
    • 40749114771 scopus 로고    scopus 로고
    • High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: A randomised trial
    • 1:CAS:528:DC%2BD1cXivVaqtb8%3D 18308250 10.1016/S1470-2045(08)70069-X
    • Pearson AD, Pinkerton CR, Lewis IJ, Imeson J, Ellershaw C, Machin D, et al. High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial. Lancet Oncol 2008;9:247-56.
    • (2008) Lancet Oncol , vol.9 , pp. 247-256
    • Pearson, A.D.1    Pinkerton, C.R.2    Lewis, I.J.3    Imeson, J.4    Ellershaw, C.5    Machin, D.6
  • 3
    • 56749151178 scopus 로고    scopus 로고
    • Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: A report from the Children's Oncology Group
    • 18704922 10.1002/pbc.21713
    • Zage PE, Kletzel M, Murray K, Marcus R, Castleberry R, Zhang Y, et al. Outcomes of the POG 9340/9341/9342 trials for children with high-risk neuroblastoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 2008;51:747-53.
    • (2008) Pediatr Blood Cancer , vol.51 , pp. 747-753
    • Zage, P.E.1    Kletzel, M.2    Murray, K.3    Marcus, R.4    Castleberry, R.5    Zhang, Y.6
  • 4
    • 80051979836 scopus 로고    scopus 로고
    • Clinical and biologic features predictive of survival after relapse of neuroblastoma: A report from the International Neuroblastoma Risk Group project
    • 3158599 21768459 10.1200/JCO.2010.34.3392
    • London WB, Castel V, Monclair T, Ambros PF, Pearson AD, Cohn SL, et al. Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project. J Clin Oncol 2011;29:3286-92.
    • (2011) J Clin Oncol , vol.29 , pp. 3286-3292
    • London, W.B.1    Castel, V.2    Monclair, T.3    Ambros, P.F.4    Pearson, A.D.5    Cohn, S.L.6
  • 5
    • 77954522656 scopus 로고    scopus 로고
    • 123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: Results of a meta-analysis
    • 1:CAS:528:DC%2BC3cXnvVaksr8%3D 20392867 10.1210/jc.2009-2604
    • Jacobson AF, Deng H, Lombard J, Lessig HJ, Black RR.123I-meta- iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis. J Clin Endocrinol Metab 2010;95:2596-606.
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 2596-2606
    • Jacobson, A.F.1    Deng, H.2    Lombard, J.3    Lessig, H.J.4    Black, R.R.5
  • 6
    • 77951675606 scopus 로고    scopus 로고
    • Development of a semi-quantitative I-123 mIBG reporting method in high risk neuroblastoma
    • Lewington V, Bar Sever Z, Giammarile F, Lynch T, McEwan A, Shulkin B, et al. Development of a semi-quantitative I-123 mIBG reporting method in high risk neuroblastoma. J Nucl Med 2009;50:1379.
    • (2009) J Nucl Med , vol.50 , pp. 1379
    • Lewington, V.1    Bar Sever, Z.2    Giammarile, F.3    Lynch, T.4    McEwan, A.5    Shulkin, B.6
  • 7
    • 0038013985 scopus 로고    scopus 로고
    • Correlation of early metastatic response by123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma
    • 12829667 10.1200/JCO.2003.09.122
    • Matthay KK, Edeline V, Lumbroso J, Tanguy ML, Asselain B, Zucker JM, et al. Correlation of early metastatic response by123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma. J Clin Oncol 2003;21:2486-91.
    • (2003) J Clin Oncol , vol.21 , pp. 2486-2491
    • Matthay, K.K.1    Edeline, V.2    Lumbroso, J.3    Tanguy, M.L.4    Asselain, B.5    Zucker, J.M.6
  • 8
    • 79954603164 scopus 로고    scopus 로고
    • 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: Diagnostic comparison and survival analysis
    • 1:CAS:528:DC%2BC3MXlslKqsb8%3D 21421719 10.2967/jnumed.110.083303
    • Papathanasiou ND, Gaze MN, Sullivan K, Aldridge M, Waddington W, Almuhaideb A, et al. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis. J Nucl Med 2011;52:519-25.
    • (2011) J Nucl Med , vol.52 , pp. 519-525
    • Papathanasiou, N.D.1    Gaze, M.N.2    Sullivan, K.3    Aldridge, M.4    Waddington, W.5    Almuhaideb, A.6
  • 9
    • 33750483287 scopus 로고    scopus 로고
    • Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma
    • 16444675 10.1002/pbc.20777
    • Messina JA, Cheng SC, Franc BL, Charron M, Shulkin B, To B, et al. Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma. Pediatr Blood Cancer 2006;47:865-74.
    • (2006) Pediatr Blood Cancer , vol.47 , pp. 865-874
    • Messina, J.A.1    Cheng, S.C.2    Franc, B.L.3    Charron, M.4    Shulkin, B.5    To, B.6
  • 10
    • 84858776675 scopus 로고    scopus 로고
    • Comparison of (18)F-dopa PET/CT and (123)I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: A pilot study
    • 1:CAS:528:DC%2BC3MXhsFOgt7bM 21932116 10.1007/s00259-011-1938-2
    • Piccardo A, Lopci E, Conte M, Garaventa A, Foppiani L, Altrinetti V, et al. Comparison of (18)F-dopa PET/CT and (123)I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study. Eur J Nucl Med Mol Imaging 2012;39:57-61.
    • (2012) Eur J Nucl Med Mol Imaging , vol.39 , pp. 57-61
    • Piccardo, A.1    Lopci, E.2    Conte, M.3    Garaventa, A.4    Foppiani, L.5    Altrinetti, V.6
  • 11
    • 84858147946 scopus 로고    scopus 로고
    • 18F-DOPA PET/CT in neuroblastoma: Comparison of conventional imaging with CT/MR
    • 22391727 10.1097/RLU.0b013e3182485172
    • Lopci E, Piccardo A, Nanni C, Altrinetti V, Garaventa A, Pession A, et al. 18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR. Clin Nucl Med 2012;37:e73-8.
    • (2012) Clin Nucl Med , vol.37
    • Lopci, E.1    Piccardo, A.2    Nanni, C.3    Altrinetti, V.4    Garaventa, A.5    Pession, A.6
  • 12
    • 84872046559 scopus 로고    scopus 로고
    • Characterization of neuroblastic tumors using 18F-FDOPA PET
    • 1:CAS:528:DC%2BC3sXhvFGjt7g%3D 23213196 10.2967/jnumed.112.102772
    • Lu MY, Liu YL, Chang HH, Jou ST, Yang YL, Lin KH, et al. Characterization of neuroblastic tumors using 18F-FDOPA PET. J Nucl Med 2013;54:42-9.
    • (2013) J Nucl Med , vol.54 , pp. 42-49
    • Lu, M.Y.1    Liu, Y.L.2    Chang, H.H.3    Jou, S.T.4    Yang, Y.L.5    Lin, K.H.6
  • 13
    • 62349083799 scopus 로고    scopus 로고
    • Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP publication 53 ICRP publication 106
    • ICRP
    • ICRP. Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP publication 53. ICRP publication 106. Ann ICRP 2008;38(1-2):1-197.
    • (2008) Ann ICRP , vol.38 , Issue.1-2 , pp. 1-197
  • 14
    • 0032293521 scopus 로고    scopus 로고
    • Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53)
    • ICRP ICRP Publication 80
    • ICRP. Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53). ICRP Publication 80. Ann ICRP 1998;28(3):1-126.
    • (1998) Ann ICRP , vol.28 , Issue.3 , pp. 1-126
  • 15
    • 0027239723 scopus 로고
    • Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment
    • 1:STN:280:DyaK3szivFCrug%3D%3D 8336186
    • Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993;11:1466-77.
    • (1993) J Clin Oncol , vol.11 , pp. 1466-1477
    • Brodeur, G.M.1    Pritchard, J.2    Berthold, F.3    Carlsen, N.L.4    Castel, V.5    Castelberry, R.P.6
  • 16
    • 34247617336 scopus 로고    scopus 로고
    • The new EANM paediatric dosage card
    • EANM Dosimetry and Paediatrics Committees 1:STN:280: DC%2BD2s3kvFKgsg%3D%3D 17406866 10.1007/s00259-007-0370-0
    • Lassmann M, Biassoni L, Monsieurs M, Franzius C, Jacobs F, EANM Dosimetry and Paediatrics Committees. The new EANM paediatric dosage card. Eur J Nucl Med Mol Imaging 2007;34:796-8.
    • (2007) Eur J Nucl Med Mol Imaging , vol.34 , pp. 796-798
    • Lassmann, M.1    Biassoni, L.2    Monsieurs, M.3    Franzius, C.4    Jacobs, F.5
  • 17
    • 77951688395 scopus 로고    scopus 로고
    • Criteria for evaluation of disease extent by 123I-metaiodobenzylguanidine scans in neuroblastoma: A report for the International Neuroblastoma Risk Group (INRG) Task Force
    • 1:STN:280:DC%2BC3c3psVSrsA%3D%3D 2865749 20424613 10.1038/sj.bjc.6605621
    • Matthay KK, Shulkin B, Ladenstein R, Michon J, Giammarile F, Levington V, et al. Criteria for evaluation of disease extent by 123I- metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force. Br J Cancer 2010;102:1319-22.
    • (2010) Br J Cancer , vol.102 , pp. 1319-1322
    • Matthay, K.K.1    Shulkin, B.2    Ladenstein, R.3    Michon, J.4    Giammarile, F.5    Levington, V.6
  • 19
    • 0025276053 scopus 로고
    • Remote, semiautomated production of 6-[18F]fluoro-L-dopa for human studies with PET
    • 1:CAS:528:DyaK3cXltlaksbw%3D 2158953 10.1016/0883-2889(90)90191-I
    • Luxen A, Perlmutter M, Bida GT, Van Moffaert G, Cook JS, Satyamurthy N, et al. Remote, semiautomated production of 6-[18F]fluoro-L-dopa for human studies with PET. Int J Rad Appl Instrum A 1990;41:275-81.
    • (1990) Int J Rad Appl Instrum A , vol.41 , pp. 275-281
    • Luxen, A.1    Perlmutter, M.2    Bida, G.T.3    Van Moffaert, G.4    Cook, J.S.5    Satyamurthy, N.6
  • 20
    • 70349904742 scopus 로고    scopus 로고
    • 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess
    • 1:CAS:528:DC%2BD1MXht12ru7bM 19622618 10.1210/jc.2009-1054
    • Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, et al. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. J Clin Endocrinol Metab 2009;94:3922-30.
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 3922-3930
    • Fiebrich, H.B.1    Brouwers, A.H.2    Kerstens, M.N.3    Pijl, M.E.4    Kema, I.P.5    De Jong, J.R.6
  • 21
    • 43149124822 scopus 로고    scopus 로고
    • Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: A novel approach with fluorodeoxyglucose-PET
    • 1:CAS:528:DC%2BD1cXlsV2gtbY%3D 18458598 10.1097/MNM.0b013e3282f813a4
    • Berkowitz A, Basu S, Srinivas S, Sankaran S, Schuster S, Alavi A. Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET. Nucl Med Commun 2008;29:521-6.
    • (2008) Nucl Med Commun , vol.29 , pp. 521-526
    • Berkowitz, A.1    Basu, S.2    Srinivas, S.3    Sankaran, S.4    Schuster, S.5    Alavi, A.6
  • 22
    • 0036301604 scopus 로고    scopus 로고
    • Utility of follow-up studies using meta-[123 I]iodobenzylguanidine scintigraphy for detecting recurrent neuroblastoma
    • 1:STN:280:DC%2BD38zks1Giug%3D%3D 12089489 10.1097/00006231-200207000- 00011
    • Okuyama C, Ushijima Y, Kubota T, Nakamura T, Kikkawa M, Nishimura T. Utility of follow-up studies using meta-[123 I]iodobenzylguanidine scintigraphy for detecting recurrent neuroblastoma. Nucl Med Commun 2002;23:663-72.
    • (2002) Nucl Med Commun , vol.23 , pp. 663-672
    • Okuyama, C.1    Ushijima, Y.2    Kubota, T.3    Nakamura, T.4    Kikkawa, M.5    Nishimura, T.6
  • 23
    • 61449184564 scopus 로고    scopus 로고
    • Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma
    • 2667809 19171710 10.1200/JCO.2008.17.6107
    • Kushner BH, Kramer K, Modak S, Cheung NK. Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma. J Clin Oncol 2009;27:1041-6.
    • (2009) J Clin Oncol , vol.27 , pp. 1041-1046
    • Kushner, B.H.1    Kramer, K.2    Modak, S.3    Cheung, N.K.4
  • 24
    • 33644847831 scopus 로고    scopus 로고
    • Neuroblastoma in adolescents: The Italian experience
    • 1:CAS:528:DC%2BD28XjtVCrtr8%3D 16475209 10.1002/cncr.21751
    • Conte M, Parodi S, De Bernardi B, Milanaccio C, Mazzocco K, Angelini P, et al. Neuroblastoma in adolescents: the Italian experience. Cancer 2006;106:1409-17.
    • (2006) Cancer , vol.106 , pp. 1409-1417
    • Conte, M.1    Parodi, S.2    De Bernardi, B.3    Milanaccio, C.4    Mazzocco, K.5    Angelini, P.6
  • 25
    • 84880313396 scopus 로고    scopus 로고
    • Current and future strategies for relapsed neuroblastoma: Challenges on the road to precision therapy
    • 1:CAS:528:DC%2BC3sXhtVShs7zN 23703550 10.1097/MPH.0b013e318299d637
    • Morgenstern DA, Baruchel S, Irwin MS. Current and future strategies for relapsed neuroblastoma: challenges on the road to precision therapy. J Pediatr Hematol Oncol 2013;35:337-47.
    • (2013) J Pediatr Hematol Oncol , vol.35 , pp. 337-347
    • Morgenstern, D.A.1    Baruchel, S.2    Irwin, M.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.